Vergoeding 2017-2021 voor ATC-subgroep J05AB : Nucleosiden en nucleotiden (excl. reverse-transcr-remmers)
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| J05AB01 Aciclovir (Zovirax ®) | 370.840 | 321.080 | 264.590 | 435.010 | 325.510 |
| J05AB06 Ganciclovir (Cymevene ®) | 44 | . | 165 | 165 | 30 |
| J05AB09 Famciclovir | 1.462.200 | 1.321.500 | 1.264.800 | 1.630.700 | 953.860 |
| J05AB11 Valaciclovir (Zelitrex ®) | 1.185.600 | 1.640.600 | 1.974.400 | 3.100.600 | 2.728.400 |
| J05AB14 Valganciclovir (Valcyte ®) | 2.792.100 | 1.107.300 | 1.068.700 | 746.300 | 670.200 |
| Totaal | 5.810.784 | 4.390.480 | 4.572.655 | 5.912.775 | 4.678.000 |